TY - JOUR
T1 - Peritonitis after liver transplantation
T2 - Incidence, risk factors, microbiology profiles, and outcome
AU - Pungpapong, Surakit
AU - Alvarez, Salvador
AU - Hellinger, Walter C.
AU - Kramer, David J.
AU - Willingham, Darrin L.
AU - Mendez, Julio C.
AU - Nguyen, Justin H.
AU - Hewitt, Winston R.
AU - Aranda-Michel, Jaime
AU - Harnois, Denise M.
AU - Rosser, Barry G.
AU - Hughes, Christopher B.
AU - Grewal, Hani P.
AU - Satyanarayana, Raj
AU - Dickson, Rolland C.
AU - Steers, Jeffrey L.
AU - Keaveny, Andrew P.
PY - 2006/8
Y1 - 2006/8
N2 - Peritonitis occurring after liver transplantation (PLT) has been poorly characterized to date. The aims of this study were to define the incidence, risk factors, microbiology profiles, and outcome of nonlocalized PLT. This was a retrospective study of 950 cadaveric liver transplantation (LT) procedures in 837 patients, followed for a mean of 1,086 days (range, 104-2,483 days) after LT. PLT was defined as the presence of at least one positive ascitic fluid culture after LT. There were 108 PLT episodes in 91 patients occurring at a median of 14 days (range, 1-102 days) after LT. Significant risk factors associated with the development of PLT by multivariate analysis included pre-LT model for end-stage liver disease score, duration of LT surgery, Roux-en-Y biliary anastomosis, and renal replacement therapy after LT. Biliary complications, intra-abdominal bleeding, and bowel leak/perforation were associated with 34.3%, 26.9%, and 18.5% of episodes, respectively. Multiple organisms, gram-positive cocci, fungus, and multidrug-resistant bacteria were isolated in 61.1%, 92.6%, 25.9%, and 76.9% of ascitic fluid cultures, respectively. The 28 fungal PLT episodes were associated with bowel leak/perforation and polymicrobial peritonitis. Patients who developed PLT after their first LT had a significantly greater risk of graft loss or mortality compared to unaffected patients. Parameters significantly associated with these adverse outcomes by multivariate analysis were recipient age at LT and bowel leak or perforation after LT. In conclusion, PLT is a serious infectious complication of LT, associated with significant intra-abdominal pathology and reduced recipient and graft survival.
AB - Peritonitis occurring after liver transplantation (PLT) has been poorly characterized to date. The aims of this study were to define the incidence, risk factors, microbiology profiles, and outcome of nonlocalized PLT. This was a retrospective study of 950 cadaveric liver transplantation (LT) procedures in 837 patients, followed for a mean of 1,086 days (range, 104-2,483 days) after LT. PLT was defined as the presence of at least one positive ascitic fluid culture after LT. There were 108 PLT episodes in 91 patients occurring at a median of 14 days (range, 1-102 days) after LT. Significant risk factors associated with the development of PLT by multivariate analysis included pre-LT model for end-stage liver disease score, duration of LT surgery, Roux-en-Y biliary anastomosis, and renal replacement therapy after LT. Biliary complications, intra-abdominal bleeding, and bowel leak/perforation were associated with 34.3%, 26.9%, and 18.5% of episodes, respectively. Multiple organisms, gram-positive cocci, fungus, and multidrug-resistant bacteria were isolated in 61.1%, 92.6%, 25.9%, and 76.9% of ascitic fluid cultures, respectively. The 28 fungal PLT episodes were associated with bowel leak/perforation and polymicrobial peritonitis. Patients who developed PLT after their first LT had a significantly greater risk of graft loss or mortality compared to unaffected patients. Parameters significantly associated with these adverse outcomes by multivariate analysis were recipient age at LT and bowel leak or perforation after LT. In conclusion, PLT is a serious infectious complication of LT, associated with significant intra-abdominal pathology and reduced recipient and graft survival.
UR - http://www.scopus.com/inward/record.url?scp=33746931273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746931273&partnerID=8YFLogxK
U2 - 10.1002/lt.20801
DO - 10.1002/lt.20801
M3 - Article
C2 - 16741932
AN - SCOPUS:33746931273
SN - 1527-6465
VL - 12
SP - 1244
EP - 1252
JO - Liver Transplantation
JF - Liver Transplantation
IS - 8
ER -